JointHealth™ express   March 30, 2021

NACI rapid response: Recommended use of AstraZeneca COVID-19 vaccine in younger adults


National Advisory Committee on Immunization (NACI) recommends that AstraZeneca COVID-19 vaccine should not be used in adults under 55 years of age at this time while the safety signal of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) following vaccination with AstraZeneca COVID-19 vaccine is investigated further.

Read NACI’s statement here:

Dive deeper: